Thromboxane B2-d9

• Description :

  Thromboxane B2-d9 is deuterium labeled Thromboxane B2. Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation[1].

• Product Name Alternative :

  PD-189659

• UNSPSC :

  12352211

• Target :

  Isotope-Labeled Compounds; Prostaglandin Receptor

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  GPCR/G Protein; Others

• Field of Research :

  Inflammation/Immunology

• Smiles :

  O[C@@H]1[C@@H]([C@H](OC(C1)O)/C=C/[C@H](CC([2H])(C([2H])(C([2H])(C([2H])([2H])[2H])[2H])[2H])[2H])O)C/C=C\CCCC(O)=O

• Molecular Formula :

  C20H25D9O6

• Molecular Weight :

  379.54

• References & Citations :

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported